2013-08-30

[DIV28SUPER] NYTimes: E-Cigarette Makers=?utf-8?Q?=E2=80=99_Ads_Echo_Tobacco_=E2=80=99s?= Heyday

From The New York Times:

ADVERTISING: E-Cigarette Makers' Ads Echo Tobacco's Heyday

Antismoking advocates criticize e-cigarette manufacturers for using the same marketing methods as big tobacco did in the 1950s and '60s.

http://nyti.ms/188DrLF


Sent from my iPad
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

2013-08-28

[DIV28SUPER] Reminder of deadline for Div 28/50 mid-year meeting symposia/breakout submissions

The Collaborative Perspectives on Addictions (Div 28/50) midyear meeting will be happening on February 28th-March 1st in lovely Atlanta Georgia. The theme is “Changing Addictive Behavior: Bench to Bedside and Back Again.”

 

The priority deadlines for breakout/symposia submissions is September 1st (submit here: www.tinyurl.com/2014CPABreakout) and for poster sessions is October 1st submit here: www.tinyurl.com/2014CPAPosters).   

 

Please join us for a wonderful meeting! 

 

Katie Witkiewitz, PhD

Division 28 CPA Program Co-Chair

Associate Professor

Department of Psychology

University of New Mexico

 

CALL FOR PROPOSALS

View the call for proposals at: www.tinyurl.com/2014CPACFP

 

·        Breakout/Symposia Proposals

o   Due September 1, 2013

o   www.tinyurl.com/2014CPABreakout 

·        Poster Proposals

o   Priority Deadline: October 1, 2013

o   www.tinyurl.com/2014CPAPosters

 

[DIV28SUPER] SAMHSA overdose prevention toolkit

----

Harm Reduction Coalition Applauds Release of SAMHSA Overdose Prevention Toolkit

Toolkit Lunch Marks International Overdose Awareness Day

In preparations to mark International Overdose Awareness Day on August 31st the Office of National Drug Control Policy (ONDCP) and the Substance Abuse and Mental Health Services Administration (SAMHSA) have released a new Opioid Overdose Prevention Toolkit. The toolkit aims to reduce the number of fatal opioid overdoses by providing education for clinicians, patients, communities, first responders, overdose survivors and family members.

The overdose prevention toolkit highlights the importance of access to naloxone, a medication that reverses the effects of overdose from opioids (heroin or prescription painkillers). "This toolkit marks growing federal support and leadership for expanding use and availability of naloxone as a central component of a comprehensive overdose prevention strategy," noted Daniel Raymond, Harm Reduction Coalition's Policy Director. "We're seeing a tremendous groundswell of support across the country for addressing overdose through overdose education and naloxone distribution programs, from parents groups and community coalitions, medical societies, substance abuse treatment and recovery groups, and state legislatures."

"Naloxone is safe, cheap and effective, and overdose prevention programs which provide naloxone – whether through health departments, first responders, harm reduction organizations, or drug treatment facilities -- are saving lives," said Dr. Sharon Stancliff, Medical Director of the Harm Reduction Coalition. Naloxone is an opioid antagonist with no potential for extra-medical use and is the gold standard medication for counteracting and reversing the effects of opioid overdose. The Harm Reduction Coalition (HRC) has been in the forefront of this push for naloxone, through advocating and providing technical assistance for overdose prevention for nearly a decade. As part of this on going work, HRC trains people who use opioids, along with their peers, allies, friends and family members on overdose prevention, recognition and response, as well as on how to use naloxone to reverse opioid overdose. As support for naloxone grows so has the evidence base. A 2012 report authored by Harm Reduction Coalition's DOPE Project Manager and colleagues published by the Centers for Disease Control and Prevention (CDC) stated that in a single year, 10,171 overdoses had been reversed by using naloxone—or around 20% of people (53,032) trained and provided with naloxone by community-based organizations. 

Overdose claimed the lives of 38,329 people the US in 2010, over 100 persons every day, exceeding the number of lives lost in road and traffic accidents or gun violence. According to the CDC, opioid analgesics (painkillers) alone, have claimed the lives of 125,000 people in the last decade. Currently, the overdose epidemic currently shows no little sign of abating and is best characterized by a steady upward trend, with a roughly five-fold increase in fatal overdoses since 1990.  

On the eve of International Overdose Awareness Day the Harm Reduction Coalition welcomes the release of the toolkit and congratulates both ONDCP and SAMHSA for a coordinated, evidence-based response to overdose prevention and for endorsing a harm reduction intervention that can save lives. Harm Reduction Coalition urges policy makers and communities to integrate broader access to naloxone into their overdose prevention strategies. In the words of ONDCP Deputy Director Michael Botticelli, "We must do more…. We have lost too many loved ones to overdose, and the deadly disease of addiction has remained for too long in the shadows. It is time to speak out."

For more information the Harm Reduction Coalition's ongoing work on overdose prevention, follow the Drug Overdose Prevention & Education Project (DOPE) Project on facebook and twitter.

 
http://store.samhsa.gov/product/SMA13-4742

 


Daniel Raymond
Policy Director
Harm Reduction Coalition
22 W. 27th Street, 5th Floor
New York, NY 10001
(212) 213-6376 x29
Fax: (212) 213-6582
raymond@harmreduction.org
www.harmreduction.org

--



--
Kelly Dunn, Ph.D.
Instructor
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

2013-08-27

[DIV28SUPER] NIH Funding Opportunity Network K18 RFA

 

 

[DIV28SUPER] CPDD Executive Officer

CPDD EXECUTIVE OFFICER
 
The Executive Committee and Board of Directors of the College on Problems of Drug Dependence (CPDDwww.cpdd.org) are pleased to announce the search for a new Executive Officer (E.O.) who will succeed Dr. Martin Adler. CPDD has been in existence since 1929 and is the longest standing group in the USA addressing problems of drug dependence and abuse. Currently, CPDD has over 1,000 members and the organization serves as an interface among governmental, industrial and academic communities maintaining liaisons with regulatory and research agencies as well as educational, treatment, and prevention facilities in the drug abuse field.

The responsibilities of the E.O. are to represent CPDD in dealings with government, industry, academia, and other organizations as related to policy positions, joint initiatives, funding and other issues that may arise. The E.O. is ad hoc to all committees of CPDD. He/she is responsible for overseeing the work of the various committees of CPDD, giving advice and direction when needed, and preparing, in collaboration with the Director of the Executive Office (Ellen Geller) the annual meeting grant from NIDA, on which he/she is both the P.I. and the Signing Officer for the organization. The E.O. is the official signator for CPDD in all legal matters, including federal, state, and local forms, as well as items related to insurance. The E.O. serves as a non-voting member of the Executive Committee and is a member of the Finance Committee. The E.O. works with Friends of NIDA and Von Scoyoc in educating members of Congress on issues related to drug abuse funding and policy. The E.O. also assists in setting up meetings with which CPDD is associated, including the annual scientific meeting of CPDD held at various locations in June of each year.

In order to accomplish the larger goals of the organization, the E.O. has to be able to work with all of the constituencies of the organization, including the Director of the Executive Office, the membership, the Officers, the Board of Directors (BOD), and the Committee Chairs. Many issues arise that require negotiating skills, people skills, and good judgment. It is the responsibility of the E.O. to integrate all of CPDD activities that have been authorized by the BOD and the officers of CPDD. In summary, the E.O. has a leadership role in CPDD and is responsible to the Executive Committee and BOD of CPDD
                                                                                                                         
Characteristics strongly recommended for candidates:
Doctoral degree (Ph.D., M.D., Psy.D., etc) and a faculty appointment at a university, medical school or other institution at the level of Professor or equivalent;
History of NIH funding as a PI in the fields covered by CPDD's membership, especially addiction and drug abuse;
Documented history of administrative and/or leadership experience;
Substantial history of service to CPDD through membership on committees, elected member of BOD, or previous elected officer of CPDD;
History of robust attendance (i.e., at least 7 of last 10 years) and presenting at CPDD; and
Ability to commit up to 50% of effort for the position.
                                                     
Interested candidates should submit a one-page letter of interest, recent CV, and answers to the questions below to Richard De La Garza, II, Ph.D. (Chair of the E.O. Search Committee) by October 15, 2013. All documents should be submitted electronically as one file to rg12@bcm.edu. Questions about the position should be E-mailed directly to Dr. De La Garza.
 
Please address the following (maximum 3-pages):
Describe your scientific background and experience.
Describe current responsibilities and how you will reallocate effort to accommodate this position.
Describe your administrative/leadership experience.  
How available would you be to travel to Washington DC or other locations for CPDD business?
Discuss your vision for CPDD and how CPDD can best serve the substance abuse research community in the future.  
How do you envision interacting with the CPDD office* at Temple University?
                                 *Information provided upon request

2013-08-23

[DIV28SUPER] Fwd: [DIVOFFICERS] UPDATED: APA Governance Changes - Implementation Work Group CALL FOR NOMINATIONS



---------- Forwarded message ----------
From: Laumeier, Emily <elaumeier@apa.org>
Date: Fri, Aug 23, 2013 at 10:23 AM
Subject: [DIVOFFICERS] UPDATED: APA Governance Changes - Implementation Work Group CALL FOR NOMINATIONS
To: DIVOFFICERS@lists.apa.org


Below is an updated version of a posting originally sent on August 22, 2013.

 

(Added information: "Travel costs for participation on the IWG will be covered by APA.")

 

Please consider posting this message to your APA division listserv.

 

Posted on behalf of Nancy Moore, PhD, MBA, Executive Director, Governance Affairs (nmoore@apa.org):

 

Council voted to adopt significant reforms at its August meeting.  As part of that effort, they asked President Bersoff to appoint an Implementation Work Group (IWG) to iron out the details associated with the newly adopted changes.  Attached please find the Call for Nominations for the IWG.  Self-nominations are welcome.  The deadline for submission is September 12, 2013.

 

(Travel costs for participation on the IWG will be covered by APA).

 

Please distribute to all divisions, SPTAs, boards and committees.  Dr. Bersoff asked that members of those groups assist in disseminating the call as broadly as possible.

 

 

Nancy Gordon Moore, PhD, MBA  

ED, Governance Affairs
American Psychological Association

Executive Office
750 First Street NE, Washington, DC 20002-4242
Tel: 202.336.6088 |  Fax: 202.336.6157

email: nmoore@apa.org  | www.apa.org

   

P Please consider the environment before printing this email.

 

 

Click on this link to unsubscribe from this list UNSUBSCRIBE

An email will automatically open with "Unsubscribe" in the subject area. Just Send the message, as is, to unsubscribe from this list..


_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

2013-08-22

[DIV28SUPER] Fwd: [DIVOFFICERS] APA Governance Changes - Implementation Work Group CALL FOR NOMINATIONS

Posted on behalf of Nancy Moore, PhD, MBA, Executive Director, Governance Affairs (nmoore@apa.org):

 

Council voted to adopt significant reforms at its August meeting.  As part of that effort, they asked President Bersoff to appoint an Implementation Work Group (IWG) to iron out the details associated with the newly adopted changes.  Attached please find the Call for Nominations for the IWG.  Self-nominations are welcome.  The deadline for submission is September 12, 2013.

 

Please distribute to all divisions, SPTAs, boards and committees.  Dr. Bersoff asked that members of those groups assist in disseminating the call as broadly as possible.

 

 

Nancy Gordon Moore, PhD, MBA  

ED, Governance Affairs
American Psychological Association

Executive Office
750 First Street NE, Washington, DC 20002-4242
Tel: 202.336.6088 |  Fax: 202.336.6157

email: nmoore@apa.org  | www.apa.org

   

P Please consider the environment before printing this email.

 

 

Click on this link to unsubscribe from this list UNSUBSCRIBE

An email will automatically open with "Unsubscribe" in the subject area. Just Send the message, as is, to unsubscribe from this list..


_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

[DIV28SUPER] 2014 CPA | Symposia Deadline Next Week!

CALL FOR PROPOSALS

View the call for proposals at: www.tinyurl.com/2014CPACFP

 

·        Breakout/Symposia Proposals

o   Due September 1, 2013

o   www.tinyurl.com/2014CPABreakout 

·        Poster Proposals

o   Priority Deadline: October 1, 2013

o   www.tinyurl.com/2014CPAPosters

 

ABOUT THE CONFERENCE

The theme for the 2014 conference is "Changing Addictive Behavior: Bench to Bedside and Back Again"

·         Atlanta, Georgia / February 28-March 1, 2014

·         Thought-provoking keynotes and cross-discipline panels

·         Interactive environment for collaboration/networking

·         Several breakout session choices

·         Poster Sessions

·         Pre-conference in-depth workshops

·         Discounted rates for Early Career Psychologists

·         Student opportunities (discounted rates, special networking, etc)

·         You don't have to be a member of either or division or APA to attend the conference!

·         CE is available!

 

 

ABOUT THE VENUE

The beautiful W Hotel in Midtown Atlanta will be the venue for our First Annual Conference. The hotel is located in the heart of Midtown and is local to public transportation. Room rates are $159 per night. Reserve your room now!

 

MORE INFORMATION

Katie Witkiewitz, PhD, Co-Chair

Jennifer Buckman, PhD, Co-Chair

Chad Rummel, MEd, Registration and Hotel Accommodations (202-336-6121)

 

 

 

2013-08-21

[DIV28M] New programming initiatives for APA2014

Dear Division 28 Colleagues,



We are excited to inform you about some new programming initiatives at
the 2014 APA Annual Convention in Washington DC. APA is implementing
cross-cutting themes and integrative programming across the different
divisions of APA to highlight the unifying nature of psychology as a
discipline.



If you have an interest or an idea for collaborative programming between
Division 28 and any other Divisions (e.g., 2-Teaching of Psychology; 6-
Behavioral Neuroscience; 25-Behavioral Analysis; 38-Health Psychology;
50-Addictions) or have collaborations already established with colleagues
from other divisions, let us help you develop your proposals.



The advantages of the collaborative programming initiative for the
Divisions are an increased number of programming hours of interest to
Division 28 members, earlier submission of symposia and programming
ideas prior to the regular deadline, a potential to bring in secondary
members from other divisions to Division 28, and some limited funding
opportunities to bring in "high draw" presenters.



The basic ground rules are that at least two divisions must participate,
innovative formats are encouraged (workshops, debates, panel
discussions), and one Division must be the Primary submitter. If a
proposal is not accepted for the collaborative programming initiative,
Division 28 can still consider your idea via the traditional division
programming process.



Drafts of potential collaborative programming are due by November 1 to
Program Chairs of the Divisions. However, since this is the first year of the
process, we encourage your ideas and suggestions earlier. Please send any
questions, ideas, or topics you would like to see at the 2014 Annual
convention to either myself (ellen.walker@temple.edu) or our Program
Chair Richard Allen (Richard.Allen@ucdenver.edu).



We look forward to hearing your ideas and hope to see you in Washington
DC!



Ellen Walker, PhD, President-Elect, Division 28



Richard Allen, PhD, 2014 Program Chair, Division 28



APA Divisions and Descriptions:
http://www.apa.org/about/division/index.aspx

__________________ Div28m@lists.apa.org ___________________
restricted to APA members subscribers corner: http://lists.apa.org

[DIV28SUPER] FUNDING OPPORTUNITY: TRAction Issues RFA for Recognition of Maternal and/or Neonatal Complications

Apologies for cross-posting: please share with interested colleagues

 


----- Original Message -----
From: TRAction.spc [mailto:TRAction.spc@URC-CHS.COM]
Sent: Friday, August 02, 2013 10:43 AM
To: tracapply <tracapply@URC-CHS.COM>
Subject: Update: TRAction Issues RFA for Recognition of Maternal and/or
Neonatal Complications

Dear Colleagues,

Please note the clarification that this RFA focuses on maternal and/or
neonatal complications.
Please help us to circulate this request for applications around issues
relating to the recognition of maternal and/or neonatal complications at the
community and household level, especially to partners in research
institutions and low-middle income countries.  You can find more information
at the link below.


[cid:image001.jpg@01CE8DE2.848E59D0]
[cid:image002.jpg@01CE8DE2.848E59D0]

TRAction Issues RFA for Recognition of Maternal and/or Neonatal
Complications

RFA #:  MNCH2013-002
Posted:  July 31, 2013
Questions Due:  August 23, 2013
Applications Due: September 27, 2013

The Translating Research into Action (TRAction) Project has issued a Request
for Applications (RFA) to document community-oriented efforts aimed at
improving recognition of and appropriate care-seeking for perceived maternal
and/or newborn complications. TRAction will fund the development of
descriptive mixed method case studies that explore the implementation of
these interventions. For the purpose of this proposal, a descriptive case
study should answer the “how” and “why” questions around how changes are
achieved (or not achieved) in a particular context, using a mixed-methods
approach. These case studies will include an assessment of the obstacles,
opportunities, and enabling factors that influenced the intervention,
including secondary data analyses.  The case studies will be shared with
national, regional and global decision-makers, program implementers,
researchers, and stakeholders to improve recognition and appropriate care
seeking interventions.

Applicants must be program implementers working in the field of RMNCH or
research institutions working in partnership with program implementers who
are currently implementing or recently completed an intervention or program
to improve recognition of and care seeking for maternal and newborn
complications in a LMIC (see full RFA for list of eligible countries).
Projects or research studies with both successful and unsuccessful
approaches are encouraged to apply.   The application includes a brief
description of the intervention and the strategy used to implement it,
results and availability of evidence/data sources as well as and future
plans for scale-up. TRAction anticipates making 2-4 awards of approximately
USD 100,000 - 125,000 each.

Applications should be submitted to
tracapply@urc-chs.com<mailto:tracapply@urc-chs.com> by Monday, September 27,
2013.

The full RFA with application details is posted here:
http://www.tractionproject.org/rfas/recognition-neonatal-complications-community-and-household-level-referral-care-and-capacity-res



TRAction Project
University Research Co., LLC
7200 Wisconsin Avenue, Suite 700
Bethesda, MD 20814
tracapply@urc-chs.com<mailto:tracapply@urc-chs.com>
www.tractionproject.org<http://www.tractionproject.org/>

 

2013-08-16

[DIV28SUPER] NIDA Neuroscience Update Aug 16, 2013

Table of Contents

 

I.                    Hold the Date for Frontiers in Addiction Research Mini-convention , Nov 8, 2013, The Westin Hotel in the Gas Lamp Quarter in San Diego

 

II.                  Other NIDA Events that will take place at the 2013 Society for Neuroscience Meeting Include:

 

Transitioning Beyond the Postdoc:  Workshop for Early Career Investigators

 

SfN Minisymposium – New Insights into the Specificity and Plasticity of Reward and Aversion Encoding in the Mesolimbic System

 

III.                Behavioral and Social Science Research on Understanding and Reducing Health Disparities

---------------------

 

I.                   Hold the Date for Frontiers in Addiction Research Mini-convention , Nov 8, 2013, The Westin Hotel in the Gas Lamp Quarter in San Diego

 

 

The NIDA Neuroscience Consortium would like to announce our plan (pending official approvals) to hold the Frontiers in Addiction Research Mini-convention as a Satellite Session at the 2013 Society for Neuroscience annual meeting.  As in past years, this meeting will provide the opportunity for you to interact with respected scientists across diverse disciplines as they describe the latest findings and discuss future directions in research related to the neuroscience of drug abuse and addiction.  The mini-convention is planned for Friday, November 8, 2013 at The Westin Hotel in the Gas Lamp Quarter in San Diego.  We plan to include several sessions aimed at discussing cutting edge research areas in neuroscience.  Please save the date. Once we receive the official approval to hold the meeting, we will disseminate detailed information via the meeting website.

 

The proposed sessions include: 

 

Emerging and Novel Aspects of Neuronal Transmission

Speakers: N.C. Spritzer, UCSD; D. L. Sabatini, Harvard; A. Wallén-Mackenzie, Uppsala University

 

Jacob P Waletzky Memorial Lecture

Speaker: The winner of the Jacob P. Waletzky Award and speaker will be announced at the mini-convention

 

Extracellular RNAs in Neuroscience:  Biology, Biomarkers, and Therapeutics

Speakers: X. Breakefield, MGH; C. Wahlestedt, U. Miami; P. Kenny, Scripps FL; M. Wood, U of Oxford

 

Advances in High Resolution and Large Scale Imaging of Brain Networks and Circuits

Speakers: K. Deisseroth, Stanford; R. Buckner, MGH; M. Schnitzer, Stanford; J. Donoghue, Brown University

 

Role of the Basal Ganglia in Addiction

Speakers: M.K. Lobo, U of Maryland; A. Kreitzer, Gladstone; S. Ferguson, U of Washington; R. Costa, NIAAA

 

For additional information please contact Mary Kautz, Ph.D. (kautzm@mail.nih.gov) or Cathrine Sasek, Ph.D. (csasek@nih.gov).

 

-------------------------

II.                 Other NIDA Events that will take place at the 2013 Society for Neuroscience Meeting Include:

 

Transitioning Beyond the Postdoc:  Workshop for Early Career Investigators

Monday, November 11, 2013

6:30-9:00 pm

San Diego Marriott Marquis

Marina Ballroom Salon D

 

Are you at the end of your postdoc?  Or are you a newly-minted independent investigator?  Are you unsure of how to proceed during this transition phase?  Then this is the workshop for you.  There will be brief presentations on what you should consider when looking for a faculty position, how a potential employer might evaluate you (presented by the Chair of a major neuroscience department), establishing your laboratory and getting the right people there (presented by the Director of an NIH Intramural Program), and suggestions aimed at making that all-important first grant application successful from choosing the right funding mechanism to helpful hints to see you through the grant process.  There will also be plenty of time for questions! 

 

Presenters:  Nancy Pilotte, Ph.D., Peter Kalivas, Ph.D., Robert Sorensen, Ph.D., and Antonello Bonci, M.D.

 

---------------------

SfN Minisymposium – New Insights into the Specificity and Plasticity of Reward and Aversion Encoding in the Mesolimbic System

Tuesday, November 12, 2013

8:30-11:00 am

 

Dopamine neurons in the ventral tegmental area (VTA) and one of their targets, the nucleus accumbens (NAc) are often referred to as the "brain reward system." But it has long been known that neurons in both of these areas also respond to aversive stimuli and events. With the advent of new anatomical, physiological, and behavioral approaches, a more sophisticated and complex understanding is emerging of how these brain areas produce both positive and negative motivational states in varying contexts. This symposium will highlight new approaches and findings, including the use of optogenetic and other techniques to identify and activate specific subcircuits, behavioral manipulations to alter the valence of stimuli depending on prior experience, and methods to investigate adaptations in coordinated neuronal activity. The speakers will demonstrate that recent research on the mesocorticolimbic system has moved well beyond questions such as "what does dopamine do?" Dr. Stephan Lammel will discuss the diverse functions of distinct subtypes of dopamine neurons in the VTA. Dr. Elyssa Margolis will discuss the heterogeneity of mu-opioid signaling in the VTA. Dr. Yunbok Kim will show how synchronized VTA neuronal firing changes during appetitive and aversive learning. Dr. Mitchell Roitman's presentation on dopamine signaling in the NAc also will show that the encoding of positive versus negative motivation in the NAc can be modulated by behavioral state and learning. Dr. Jocelyn Richard's talk will focus on how specific inputs from the prefrontal cortex bias motivational valence in the NAc. Finally, Dr. Mary Kay Lobo will discuss the distinct roles in motivational control of the NAc's two major outputs, the direct and indirect pathway medium spiny neurons.

 

Chair:  Susan Volman, Ph.D., NIDA

 

--------------------------

III.              Behavioral and Social Science Research on Understanding and Reducing Health Disparities

 

R01: PA-13-292 http://grants.nih.gov/grants/guide/pa-files/PA-13-292.html

R21: PA-13-288 http://grants.nih.gov/grants/guide/pa-files/PA-13-288.html

 

Application due dates: standard due dates apply

Expiration date: September 8, 2016

 

Please note this FOA is a reissue of PAR-10-136 (http://grants.nih.gov/grants/guide/pa-files/PAR-10-136.html) and PAR-10-137 (http://grants.nih.gov/grants/guide/pa-files/PAR-10-137.html).

The National Institutes of Health (NIH) issues this Funding Opportunity Announcement (FOA) to encourage research project grant applications (R01, R21) employing behavioral and social science theories, concepts, and methods (1) to improve understanding of the causes of disparities in health and disability among the various populations of the United States and (2) to develop and test interventions for reducing and eventually eliminating health disparities. The purpose of this FOA is to encourage behavioral and social science research on the causes and solutions to health and disabilities disparities in the U. S. population.

 

-----------------

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to istserv@list.nih.gov<mailto:listserv@list.nih.gov>, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309

2013-08-08

[DIV28SUPER] NYTimes: Smoking Is Back, Without the Stigma

http://nyti.ms/1317CXE

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

2013-08-07

[DIV28SUPER] Fwd: Call for Nominations: 2014 APF Charles L. Brewer Distinguished Teaching of Psychology Award



Sent from my iPad

Begin forwarded message:

From: "Edington, Samantha" <sme@apa.org>
Date: August 7, 2013, 1:38:36 PM EDT
Subject: Call for Nominations: 2014 APF Charles L. Brewer Distinguished Teaching of Psychology Award

Dear Sir or Madam:

 

You are being sent this announcement because you are the owner of a Division listserv. Attached you will find a Request for Nominations for the American Psychological Foundation's (APF) 2014 Charles L. Brewer Distinguished Teaching of Psychology Award, which recognizes significant career contributions of a psychologist who has a proven track record as an exceptional teacher of psychology. This $2,000 award also includes an all-expense paid round trip, and plaque presented at the APA convention. The deadline for nominations is December 1, 2013. Please consider publishing this announcement in your next message and feel free to forward the call to anyone you think might be interested. Thank you for your time.

 

Best,

 

Samantha Edington

Program Officer

American Psychological Foundation

750 First Street, NE

Washington, DC 20002

P: (202) 336-5984 I F: (202) 336-5812

www.apa.org/apf

 

2013-08-05

[DIV28SUPER] Faculty ad for positions at Binghamton University for DIV28 listserve

Hi all. 

Hope your summer is going well.  Attached is an ad for two faculty openings at Binghamton – exciting opportunities for the right people! 

Cordially,

 

Linda Spear

 

Linda Patia Spear

SUNY Distinguished Professor, Department of Psychology and

Director, Developmental Exposure Alcohol Research Center (DEARC)

Binghamton University  Box 6000

Binghamton, NY  13902-6000

lspear@binghamton.edu

607-777-2825; FAX: 777-6418

http://binghamton.edu/psychology/adolescent-alcohol